ICU Medical Inc
ICUI142.670USD
-1.960-1.36%
收盘 12/31, 16:00（美东）报价延迟15分钟
3.52B总市值
亏损市盈率 TTM
关于 ICU Medical Inc 公司
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
ICU Medical Inc简介
公司代码ICUI
公司名称ICU Medical Inc
上市日期Mar 31, 1992
CEOJain (Vivek)
员工数量15000
证券类型Ordinary Share
年结日Mar 31
公司地址951 Calle Amanecer
城市SAN CLEMENTE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编92673-6212
电话19493662183
网址https://www.icumed.com/
公司代码ICUI
上市日期Mar 31, 1992
CEOJain (Vivek)
ICU Medical Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
155.21K
-29.08%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
30.35K
+21.62%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
11.30K
-20.41%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
8.46K
+16.53%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
6.09K
+154.83%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
4.75K
+56.92%
Ms. Laurie Hernandez
Ms. Laurie Hernandez
Independent Director
Independent Director
3.61K
+91.41%
Ms. Kolleen T. Kennedy
Ms. Kolleen T. Kennedy
Independent Director
Independent Director
3.29K
+110.31%
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
3.25K
--
Mr. Donald M. Abbey
Mr. Donald M. Abbey
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
155.21K
-29.08%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
30.35K
+21.62%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
11.30K
-20.41%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
8.46K
+16.53%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
6.09K
+154.83%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
4.75K
+56.92%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Infusion Consumables
273.13M
49.76%
Consumables
273.13M
49.76%
Infusion Systems
167.70M
30.55%
Vital Care
108.04M
19.68%
地区USD
名称
营收
占比
United States
335.43M
61.11%
EMEA
99.06M
18.05%
APAC
58.40M
10.64%
Others
55.97M
10.20%
业务
地区
业务USD
名称
营收
占比
Infusion Consumables
273.13M
49.76%
Consumables
273.13M
49.76%
Infusion Systems
167.70M
30.55%
Vital Care
108.04M
19.68%
股东统计
更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.04%
The Vanguard Group, Inc.
10.61%
Janus Henderson Investors
10.02%
Wasatch Global Investors Inc
10.01%
Fuller & Thaler Asset Management Inc.
5.61%
其他
50.72%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.04%
The Vanguard Group, Inc.
10.61%
Janus Henderson Investors
10.02%
Wasatch Global Investors Inc
10.01%
Fuller & Thaler Asset Management Inc.
5.61%
其他
50.72%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
56.82%
Investment Advisor
46.66%
Hedge Fund
8.58%
Research Firm
2.66%
Corporation
1.90%
Pension Fund
1.43%
Sovereign Wealth Fund
1.17%
Individual Investor
0.96%
Bank and Trust
0.64%
机构持股
更新时间: 2 小时前
更新时间: 2 小时前
报告期
机构数
持股数
持股占比
持股变动
2025Q4
603
29.26M
118.52%
+2.55M
2025Q3
610
27.90M
113.00%
+1.26M
2025Q2
610
25.98M
105.53%
-2.00M
2025Q1
626
27.13M
110.25%
-2.28M
2024Q4
608
26.46M
107.92%
-3.56M
2024Q3
587
26.75M
109.35%
-2.77M
2024Q2
567
27.24M
111.60%
-1.50M
2024Q1
579
26.01M
106.82%
-1.69M
2023Q4
588
25.74M
106.69%
-1.14M
2023Q3
580
26.53M
109.94%
-1.49M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
3.22M
13.04%
-42.28K
-1.30%
Sep 30, 2025
The Vanguard Group, Inc.
2.62M
10.61%
-33.51K
-1.26%
Sep 30, 2025
Janus Henderson Investors
2.47M
10.02%
+3.39K
+0.14%
Sep 30, 2025
Wasatch Global Investors Inc
2.47M
10.01%
+2.47M
--
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.39M
5.61%
-4.81K
-0.35%
Sep 30, 2025
Millennium Management LLC
1.09M
4.41%
+690.69K
+173.40%
Sep 30, 2025
State Street Investment Management (US)
917.13K
3.72%
-10.67K
-1.15%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
872.99K
3.54%
+126.07K
+16.88%
Sep 30, 2025
Schroder Investment Management North America Inc.
796.70K
3.23%
+160.38K
+25.20%
Sep 30, 2025
Columbia Threadneedle Investments (US)
763.73K
3.09%
+187.22K
+32.48%
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco S&P SmallCap Health Care ETF
1.82%
State Street SPDR S&P Health Care Equipment ETF
1.6%
JPMorgan Active Small Cap Value ETF
0.79%
Invesco S&P SmallCap 600 Pure Growth ETF
0.78%
JPMorgan Fundamental Data Science Small Core ETF
0.68%
Invesco NASDAQ Future Gen 200 ETF
0.51%
iShares S&P Small-Cap 600 Growth ETF
0.47%
State Street SPDR S&P 600 Small Cap Growth ETF
0.41%
OneAscent Enhanced Small and Mid Cap ETF
0.4%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.38%
查看更多
Invesco S&P SmallCap Health Care ETF
占比1.82%
State Street SPDR S&P Health Care Equipment ETF
占比1.6%
JPMorgan Active Small Cap Value ETF
占比0.79%
Invesco S&P SmallCap 600 Pure Growth ETF
占比0.78%
JPMorgan Fundamental Data Science Small Core ETF
占比0.68%
Invesco NASDAQ Future Gen 200 ETF
占比0.51%
iShares S&P Small-Cap 600 Growth ETF
占比0.47%
State Street SPDR S&P 600 Small Cap Growth ETF
占比0.41%
OneAscent Enhanced Small and Mid Cap ETF
占比0.4%
Vanguard S&P Small-Cap 600 Growth Index Fund
占比0.38%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
ICU Medical Inc的前五大股东是谁？
ICU Medical Inc 的前五大股东如下：
BlackRock Institutional Trust Company, N.A.持有股份：3.22M，占总股份比例：13.04%。
The Vanguard Group, Inc.持有股份：2.62M，占总股份比例：10.61%。
Janus Henderson Investors持有股份：2.47M，占总股份比例：10.02%。
Wasatch Global Investors Inc持有股份：2.47M，占总股份比例：10.01%。
Fuller & Thaler Asset Management Inc.持有股份：1.39M，占总股份比例：5.61%。
BlackRock Institutional Trust Company, N.A.持有股份：3.22M，占总股份比例：13.04%。
The Vanguard Group, Inc.持有股份：2.62M，占总股份比例：10.61%。
Janus Henderson Investors持有股份：2.47M，占总股份比例：10.02%。
Wasatch Global Investors Inc持有股份：2.47M，占总股份比例：10.01%。
Fuller & Thaler Asset Management Inc.持有股份：1.39M，占总股份比例：5.61%。
ICU Medical Inc的前三大股东类型是什么？
ICU Medical Inc 的前三大股东类型分别是：
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Janus Henderson Investors
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Janus Henderson Investors
有多少机构持有ICU Medical Inc(ICUI)的股份？
截至2025Q4，共有603家机构持有ICU Medical Inc的股份，合计持有的股份价值约为29.26M，占公司总股份的118.52%。与2025Q3相比，机构持股有所增加，增幅为5.52%。
哪个业务部门对ICU Medical Inc的收入贡献最大？
在FY2025Q2，Infusion Consumables业务部门对ICU Medical Inc的收入贡献最大，创收273.13M，占总收入的49.76%。
